Zeichner explains that although the exact cause of seborrheic dermatitis is unknown, the body overreacts to yeast on oily parts of the skin, causing the thick, flaky buildup
These prescription medications have dramatically reshaped the approach to obesity and metabolic health, providing individuals with new hope for long-term success
Semaglutide: Long-Acting GLP-1 for Weekly Dosing Semaglutide is a synthetic GLP-1 receptor agonist designed to last seven days per injection or oral dose, allowing once-weekly treatment schedules
Infant and young child feeding: model chapter for textbooks for medical students and allied health professionals
Not just Healing but Optimizing yourself with BPC-157 Along with being found to heighten the healing of several types of tissues, BPC-157 also appears to support the longevity of cells at the sites of wounds
But a 2026 report published in Diabetes, Obesity and Metabolism suggests the effects of discontinuing treatment extend beyond the scale